The Antiarrhythmic Drug, Amiodarone, Decreases AKT Activity and Sensitizes Human Acute Myeloid Leukemia Cells to Apoptosis by ABT-263

The American Journal of the Medical Sciences
Corey J KetchemLevi J Beverly

Abstract

Successful treatment of leukemia requires new medications to combat drug resistance, but the development of novel therapies is an arduous and risky endeavor. Repurposing currently approved drugs or those already in clinical development to treat other indications is a more practical approach. Moreover, combinatorial therapeutics are often more efficacious than single agent therapeutics because the former can simultaneously target multiple pathways that mitigate tumor aggressiveness and induce cancer cell death. In this study, we combined the class III antiarrhythmic agent amiodarone and the BH3 mimetic ABT-263 based on data from a prior drug screen to assess the degree of apoptotic induction in 2 human leukemia cell lines. The combination yielded statistically significant increases in apoptosis in both cell lines by downregulating AKT activity and increasing cleaved caspase-3. Overall, our findings suggest that combining K+ channel blockers with prosurvival Bcl-2 family inhibitors is a promising therapeutic approach in treating leukemia.

References

Apr 29, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T KarakasL Bergmann
Apr 20, 1999·Naunyn-Schmiedeberg's Archives of Pharmacology·J KiehnW Kübler
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Jul 3, 2002·Nature Reviews. Cancer·Igor Vivanco, Charles L Sawyers
May 3, 2008·Cancer Research·Christin TseSteven W Elmore
Sep 12, 2008·Journal of Medicinal Chemistry·Theodossis A TheodossiouConstantinos M Paleos
Sep 27, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ildikò SzabóErich Gulbins
Jan 26, 2010·Cancer Chemotherapy and Pharmacology·Scott AcklerAlexander R Shoemaker
Apr 26, 2011·Biochemical and Biophysical Research Communications·Meike VoglerGerald M Cohen
Sep 24, 2011·American Journal of Physiology. Cell Physiology·V'yacheslav Lehen'kyiNatalia Prevarskaya
Dec 30, 2011·Current Medicinal Chemistry·A ArcangeliA Becchetti
Aug 27, 2013·Molecular Cancer Therapeutics·Christian Billard
Dec 18, 2013·Nature Reviews. Cancer·Luis A Pardo, Walter Stühmer
Jan 29, 2014·Oncogene·L LeanzaI Szabo
Sep 4, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emil J FreireichDavid P Steensma
Feb 3, 2015·Advances in Cancer Research·Yu FukudaJohn D Schuetz
Sep 17, 2015·The New England Journal of Medicine·Hartmut DöhnerClara D Bloomfield
Dec 15, 2015·Biochimica Et Biophysica Acta·Luigi LeanzaIldiko Szabo

❮ Previous
Next ❯

Citations

Feb 20, 2020·Cancers·Anna V WojcickiKathleen M Sakamoto
Jun 21, 2020·Journal of Clinical Medicine·Debora ValliMyriam Alcalay
Oct 24, 2020·Scientific Reports·Eliana SteinbergOfra Benny

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.